Try our Advanced Search for more refined results
February 04, 2013
Purdue Pharma L.P. et al v. Watson Laboratories, Inc. et al
Case Number:
1:13-cv-00762
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 26, 2013
Purdue, Actavis Settle OxyContin Patent Battle
Purdue Pharma LP and Actavis Inc. announced Friday that they've agreed to end a New York patent infringement suit seeking to block Actavis' generic version of abuse-deterrent formulations of Purdue's multibillion-dollar drug OxyContin.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login